Page 49 - Felix Nipkow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Felix nipkow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Felix Nipkow Today - Breaking & Trending Today

First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company's Phase III ProstACT GLOBAL study of its investigational prostate-specific membrane antigen (PSMA) targeting radio-antibody drug conjugate (rADC) therapy, TLX591 (177Lu-rosopatamab tetraxetan). TLX591 is a rADC composed of a high-specificity PSMA-targeting antibody, chelator linker, and cytotoxic lutetium (177Lu) payload. The PSMA-targeted monoclonal antibody (mAb) ap ....

United States , United Kingdom , Nat Lenzo , Colin Hayward , Telix Pharmaceuticals , Telix Pharmaceuticals Limited Disclosure Committee , Australian Securities Exchange , Drug Administration , Genesiscare Group Clinical , Genesiscare Contract Research Organisation , Health Canada , Australian Therapeutic Goods Administration , God Hospital Murdoch , Genesiscare Group Clinical Director Theranostics , Principal Investigator , Group Chief Medical Officer , Professor Lenzo , Telix Pharmaceuticals Limited , Contract Research Organisation , Global Study , Prostate Cancer , Telix Pharmaceuticals Limited , Phase Iii Study , Phase Iii , Safety Profile , Monoclonal Antibody ,

Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with Denmark-based WIIK Pharma ApS (Wiik Pharma) for the distribution of Telix's investigational prostate cancer imaging agent, Illuccix® (TLX591-CDx, Kit for the preparation of 68Ga-PSMA-11 injection) in the Nordic region. ....

United Kingdom , United States , Wiik Pharma , Kyahn Williamson , Yacoub Amin , Drug Administration , Corporate Communications , Health Canada , Australian Securities Exchange , Telix Pharmaceuticals , European Union , Australian Therapeutic Goods Administration , Middle East , Prostate Cancer , Pharma Aps , Marketing Authorisation Applications , Telix Pharmaceuticals Limited , Nordic Region , Iik Pharma Aps , Prostate Cancer ,

Cone Health launches genomics testing program

Cone Health and Helix have partnered to launch a population genomics testing program to identify people at risk for diseases and conditions based on inherited. ....

N Cone Health , Cone Health , One Health , Population Genomics , Testing Program , Genetic Predisposition , Nherited Genetic Mutations ,

Telix to Present at Jefferies London Healthcare Conference 2023

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that Dr Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies London Healthcare Conference 2023. ....

United States , United Kingdom , Kyahn Williamson , Corporate Communications , Australian Securities Exchange , Australian Therapeutic Goods Administration , European Union , Health Canada , Drug Administration , Telix Pharmaceuticals , Marketing Authorisation Applications , Telix Pharmaceuticals Limited , Jefferies London Healthcare Conference ,

Parks for Purchase: Why Port Arthur is selling 6 of its parks, how the money will be spent

Three Port Arthur Parks are now on the market, ready for a new buyer, and another three will soon join them. ....

Bron Burton , Rose Hill , Chandra Alpough , Port Arthur City Council , Three Port Arthur Parks , Civic Park , Milton Barker Park , Immigrant Park , Carver Terrace Park , Montgomery Park , Hughen Park , Port Arthur Parks , Recreation Director , Port Arthur Citizens , Adams Park , Manager Ron Burton , Carver Terrace , Port Arthur , Hospitality Recreation , Parks And Recreation ,